Colfax Corporation CFX

Full chart Compare
Set alert

Price alert · CFX

All alert types
39.06 +39.06

Day range unavailable

52-week range unavailable

Market cap
2.10B
Revenue (ttm)
3.85B
Profit margin
1.86%
Shares out
53.78M
Forward P/E
14.52
Beta
2.12
Analysts
Buy
Price target
50.42 (+29.1%)
Earnings date
May 5, 2022

2Y -13.79 (-26.09%)

35404550Nov 21Dec 21Jan 22Feb 22Mar 2239.06

Key statistics

Enterprise value
5.39B
PEG ratio
1.13
Price / sales
0.54
Price / book
0.44
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
23.60%
Free cash flow
264.89M
Total cash
719.37M
Total debt
2.27B
Return on equity
2.39%
Short % of float
5.57%
50-day average
69.21
200-day average
78.15

Earnings

CFX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
May 5, 2022Mar 1, 20220.49———
Feb 22, 2022Dec 1, 20210.57———
Nov 4, 2021Sep 1, 20210.54———
Jul 28, 2021Jun 1, 20210.53———
Apr 29, 2021Mar 1, 20210.39———
Feb 18, 2021Dec 1, 20200.49———

Upgrades / downgrades

CFX analyst upgrades and downgrades
DateFirmActionFromTo
Mar 15, 2022Morgan Stanleymain—Equal-Weight
Mar 15, 2022Keybancmain—Overweight
Feb 23, 2022Stifelmain—Buy
Feb 8, 2022Seaport GlobaldownBuyNeutral
Jan 28, 2022Morgan Stanleymain—Equal-Weight
Jan 14, 2022Morgan Stanleymain—Equal-Weight

About Colfax Corporation

Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.

Sector
Industrials
Industry
Specialty Industrial Machinery
Country
United States

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on CFX — it syncs with the Stock Master app.

Insider holders

CFX insider holders
InsiderRelationLatest transactionDateShares held
ALLENDER PATRICK WDirectorStock Award(Grant)Dec 30, 2021291,055
HIX CHRISTOPHER MChief Financial OfficerSaleFeb 28, 2022143,417
KAMBEYANDA SHYAMOfficerSaleMar 6, 2022100,985
LANG PATRICIA AOfficerSaleMar 6, 202233,105
PITTS DOUGLAS JOfficerSaleFeb 27, 20229,032
PRYOR DANIEL AOfficerSaleMar 6, 2022205,487